Emotion Discrimination Task (EDT)
OtherIt estimates the subjective bias and sensitivity in discriminating between happy and angry facial expressions of different intensities of emotional expression
NCT Number: NCT06566651
The goal of this observational study is to learn about the emotional perception in people with ALS disease compared to people with other neuromuscular disease and healthy controls. The main questions it aims to answer are:
* How people with ALS judge happy and angry faces and what their "insight" into these judgements are like * How their autonomic responses differ from the other two test group Participants will asked to judge if a face presents a happy emotion or angry emotion.
Researchers will compare the ALS group responses with neuromuscular diseases group and healthy control group responses to see if the ALS group judge more happy faces than angry.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Aarhus University Hospital, Aarhus, Central Jutland, Denmark
Mild cognitive and behavioral changes occur in 35% of ALS patients and 10-15% of patients meet the criteria for FTD1-4. Recent research suggests changes in emotional perception and social cognition are a part of the neuropsychological changes in ALS, possibly associated with cognitive and behavioral symptoms seen in ALS-FTD5-9.
The aim of this project is to investigate emotional perception in ALS patients compared to healthy controls and patients with other neuromuscular diseases that do not affect the central nervous system. We use a simple emotion discrimination task to evaluate emotional bias and metacognition of emotion discrimination. Moreover, this project aims to explore the correlation between emotion perception and autonomic reactivity in ALS patients by recording heart rate frequency and respiration frequency during the EDT.
The project will contribute with deeper insights to the neuropsychological changes in ALS patients and the opportunity to quantify these changes. Thereby, the project will add new perspectives to the discussion of how we evaluate socio-emotional aspects of ALS in both clinical decision-making, guidance of relatives and future research.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
● Familial predisposition to ALS
It estimates the subjective bias and sensitivity in discriminating between happy and angry facial expressions of different intensities of emotional expression
Time frame: 20 minutes
The EDT requires subjects to assess the facial emotion of a face stimulus and report whether the facial emotion was angry or happy. This will be the operationalisation of subjects' emotion perception, which we anticipate will reveal a bias towards positive perceptions. There is thus two scores on this scale: "Angry" and "Happy". There is no one of these scores that is "better" than the other. It is an nominal categorical scare.
Time frame: 20 minutes
Metacognitive insight will be operationalized through a metacognitive sensitivity measure. The method employed for this is a confidence rating measure, where subjects assess their own performance on the EDT. Subjects will indicate on a sliding scale, ranging from "very confident" (maximum score) to a "pure guess" (minimum score), how confident they are that their previous answer was correct. Generally higher scores on this scale is considered better. This scales title is: " Confidence Rating Scale".
Time frame: 20 minutes
Subjects heart rate is measured through a standard 3-lead electrocardiogram montage. Electrodes were place on both collarbones and on the left lower rib.
Time frame: 20 minutes
Subjects' respiration is measured using a respiratory belt around the upper torso.
Contact information is provided by the study sponsor or research team.
Camilla Hakala, Bach.psych
CONTACT
Mia B Heintzelmann, Cand.med
CONTACT
University of Aarhus
Other
Emotion and Interoception Processing in ALS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01495390
ALS, Amyotrophic Lateral Sclerosis
Phoenix, Arizona, United States
View Trial DetailsNCT04380649
Alternative Communication Devices, Amyotrophic Lateral Sclerosis
Nice, Provence-Alpes-Côte d'Azur Region, France
View Trial DetailsNCT03127514
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07093268
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Birtinya, Queensland, Australia
View Trial Details